henipavirus
zoonot
virus
caus
sever
acut
respiratori
diseas
enceph
human
date
vaccin
treatment
approv
human
use
presenc
neutral
antibodi
strong
correl
protect
lethal
diseas
anim
howev
sinc
rna
virus
prone
high
mutat
rate
possibl
virus
escap
neutral
remain
potenti
concern
present
studi
gener
neutralizationescap
mutant
use
differ
monoclon
antibodi
studi
effect
neutralizationescap
mutat
vitro
vivo
fit
data
provid
mechan
overcom
neutral
escap
use
cocktail
crossneutr
monoclon
antibodi
recogn
residu
within
glycoprotein
import
viru
replic
virul
henipavirus
hnv
emerg
zoonot
virus
belong
famili
paramyxovirida
genu
henipaviru
current
compos
virus
hendra
viru
hev
nipah
viru
niv
cedar
viru
outbreak
hev
niv
infect
occur
almost
yearli
hors
andor
human
human
casefat
rate
rang
current
vaccin
therapeut
approv
use
human
neutral
antibodi
strong
correl
protect
experiment
anim
challeng
model
wellcharacter
human
neutral
monoclon
antibodi
use
compassionateus
basi
individu
high
risk
exposur
hev
australia
individu
high
risk
exposur
niv
unit
state
sever
neutral
monoclon
antibodi
mab
describ
target
hnv
glycoprotein
g
g
type
ii
transmembran
glycoprotein
ntermin
cytoplasm
tail
transmembran
domain
ctermin
ectodomain
divid
stalk
region
globular
head
domain
globular
head
domain
involv
receptor
bind
stalk
region
involv
trigger
fusion
protein
f
induc
viruscel
fusion
main
mechan
neutral
involv
block
interact
hnv
g
receptor
ephrin
block
viru
attach
block
induct
fusion
recent
crystal
structur
hev
g
bound
deriv
human
mab
solv
show
interact
involv
bind
hydrophob
pocket
also
engag
hnv
receptor
suggest
direct
competit
receptorbind
site
data
show
neutral
mab
promis
candid
prophylact
prevent
treatment
hnv
infect
howev
high
mutat
rate
associ
rna
viru
replic
also
increas
concern
mutat
confer
escap
neutral
therefor
import
understand
mechan
neutral
escap
potenti
impact
viral
fit
identifi
character
sever
neutralizationescap
mutat
gener
vitro
panel
human
mous
mab
assess
impact
virul
wellestablish
lethal
hamster
model
approv
anim
experi
obtain
univers
texa
medic
branch
institut
anim
care
use
committe
anim
work
perform
certifi
staff
associ
assess
accredit
laboratori
anim
careapprov
facil
anim
hous
care
experiment
protocol
accord
nation
institut
health
guidelin
hev
niv
strain
malaysia
nivm
niv
strain
bangladesh
nivb
kindli
provid
special
pathogen
branch
center
diseas
control
prevent
atlanta
georgia
virus
propag
vero
cell
atcc
describ
previous
panel
hnv
gspecif
mab
use
studi
mab
hnv
gener
describ
previous
mous
mab
gener
nivm
mous
mab
human
mab
gener
hev
neutralizationresist
nivm
hev
mutant
gener
describ
previous
neutral
titer
determin
plaqu
reduct
neutral
titer
prnt
assay
prnt
mab
serial
dilut
incub
plaqueform
unit
pfu
nivm
nivb
hev
hour
viru
antibodi
mixtur
ad
plate
vero
cellswel
triplic
incub
hour
cell
overlaid
ml
agaros
medium
plate
incub
day
stain
crystal
violet
formalin
plaqu
count
percentag
neutral
calcul
number
plaqu
antibodynumb
plaqu
without
antibodi
assay
perform
triplic
crystal
structur
coordin
hev
nivm
attach
protein
g
interact
receptor
human
ephrin
pdb
code
respect
use
determin
locat
amino
acid
residu
associ
neutral
escap
molecular
represent
produc
pymol
delano
scientif
growth
curv
perform
inocul
vero
cell
cultur
nivm
hev
escap
mutant
low
multipl
infect
moi
hour
cell
wash
time
phosphatebuff
salin
overlaid
medium
viru
sampl
obtain
variou
time
point
infect
store
viral
titer
determin
tissu
infect
cultur
dose
tcid
assay
previous
describ
femal
syrian
golden
hamster
mesocricetu
auratu
hsdhan
aura
hamster
harlan
laboratori
inocul
tcid
hev
nivm
respect
neutralizationescap
mutant
volum
via
intraperiton
rout
monitor
describ
previous
pathogenesi
studi
group
anim
euthan
day
infect
moribund
wholeblood
sampl
collect
vacutain
tube
contain
ethylenediaminetetraacet
acid
well
spleen
kidney
lung
brain
remov
viru
isol
viru
titrat
tissu
sampl
perform
describ
previous
identif
amino
acid
critic
hnv
neutral
mab
use
select
neutralizationescap
mutant
hev
mab
use
select
neutralizationescap
mutant
nivm
mab
previous
use
gener
neutralizationescap
mutant
hev
nivm
five
escap
mutant
contain
singl
amino
acid
chang
g
escap
mutant
gener
use
mab
result
amino
acid
chang
g
supplement
tabl
previous
show
escap
mutant
result
amino
acid
chang
nivm
g
posit
hev
g
posit
escap
mutant
contain
singl
amino
acid
chang
posit
nivm
g
interestingli
mab
neutralizationescap
mutant
contain
amino
acid
chang
posit
addit
chang
neutralizationescap
mutant
contain
mutat
posit
wherea
mab
mutant
contain
mutat
hev
g
amino
acid
chang
present
posit
escap
mutant
final
gener
neutralizationescap
mutant
use
mab
result
amino
acid
chang
posit
hev
g
unfortun
hybridoma
produc
mab
use
gener
escap
mutant
lost
owe
technic
failur
storag
thu
analys
perform
mab
first
neutral
antibodi
titer
mab
hev
nivm
nivb
determin
figur
mab
abl
neutral
hev
nivm
nivb
effici
figur
mab
neutral
nivm
nivb
hev
figur
mab
effici
neutral
hev
none
niv
strain
figur
second
determin
whether
mab
could
still
neutral
escap
mutant
describ
figur
neutral
mab
affect
respect
escap
mutat
nivm
hev
figur
mutat
gener
mab
neutral
mab
affect
respect
nivm
escap
mutant
posit
also
mutat
figur
origin
gener
mab
interestingli
mutat
combin
chang
affect
neutral
suggest
mutat
involv
escap
neutral
addit
mab
gener
niv
g
antibodi
also
potent
neutral
hev
sever
mutat
hev
g
associ
decreas
neutral
mab
includ
mutat
posit
figur
mab
neutral
affect
viru
strain
figur
also
respect
escap
mutat
figur
mutat
combin
chang
result
loss
neutral
final
neutral
affect
mutat
hev
g
posit
similar
figur
better
understand
mechan
neutral
locat
amino
acid
chang
associ
neutral
escap
map
structur
niv
hev
g
unfortun
structur
stalk
region
hev
g
residu
avail
therefor
unabl
map
mutat
residu
mutat
residu
associ
escap
neutral
mab
locat
near
one
bind
pocket
interact
residu
ephrin
includ
hev
g
figur
mutat
next
residu
part
bind
pocket
ephrin
residu
figur
close
proxim
escap
mutat
bind
pocket
suggest
mab
neutral
hev
interf
receptor
bind
two
mutat
associ
escap
neutral
nivm
previous
shown
import
form
stabil
nivm
gephrin
complex
residu
nivm
g
involv
van
der
waal
interact
residu
ephrin
part
one
receptorbind
pocket
figur
wherea
residu
nivm
g
part
intric
sidechainsidechain
hydrogen
bond
network
interact
residu
ephrin
figur
therefor
mab
mab
target
receptorbind
domain
result
direct
blockad
interact
nivm
receptor
ephrin
like
mechan
neutral
mutat
associ
escap
nivm
neutral
mab
locat
next
bottom
face
globular
head
nivm
g
near
stalk
domain
figur
sinc
area
known
interact
receptor
ephrin
mechan
action
remain
unknown
sinc
sever
neutralizationescap
mutat
locat
near
receptorbind
site
determin
whether
mutat
would
affect
fit
escap
mutant
vitro
plaqu
morpholog
wildtyp
wt
neutralizationescap
mutant
similar
data
shown
hev
escap
mutant
grew
similar
peak
titer
similar
kinet
vero
cell
compar
wt
hev
strain
figur
similarli
nivmderiv
escap
mutant
grew
peak
titer
hour
infect
howev
escap
mutant
contain
mutat
significantli
delay
replic
hour
infect
compar
wt
strain
figur
sinc
vitro
replic
alway
correl
vivo
virul
next
determin
virul
escap
mutant
hamster
hev
mutat
g
associ
escap
neutral
significantli
affect
virul
hamster
major
anim
succumb
diseas
around
day
figur
interestingli
anim
challeng
mutant
slight
delay
time
death
day
anim
surviv
figur
vitro
fit
affect
mutat
niv
g
associ
neutral
escap
mutat
significantli
affect
virul
hamster
hamster
infect
wt
nivm
succumb
infect
day
challeng
figur
interestingli
escap
mutant
amino
acid
chang
posit
uniformli
lethal
show
signific
delay
time
death
day
figur
infect
hamster
wt
hev
niv
result
system
replic
viru
previous
shown
infecti
hev
niv
could
detect
brain
lung
spleen
kidney
anim
evid
viremia
day
infect
data
shown
anim
moribund
hev
dissemin
neutralizationescap
mutant
similar
wt
strain
except
mutat
result
lack
dissemin
tissu
day
complet
lack
detect
viru
replic
lung
figur
addit
anim
infect
mutant
significantli
lower
level
viru
brain
figur
vitro
growth
characterist
wildtyp
nipah
viru
niv
hendra
viru
hev
neutralizationescap
mutant
cultur
vero
infect
triplic
wildtyp
neutralizationescap
mutant
hev
niv
strain
malaysia
nivm
b
multipl
describ
materi
method
section
viru
titer
differ
time
point
determin
tissu
infect
cultur
dose
tcid
assay
use
vero
cell
error
bar
repres
standard
deviat
p
analysi
varianc
compar
wildtyp
strain
figur
mutat
nivm
g
residu
result
replic
level
detect
lung
brain
moribund
hamster
figur
mutat
result
level
replic
lung
brain
similar
wt
nivm
figur
discuss
perform
detail
analysi
residu
critic
hnv
neutral
differ
mab
focus
g
sinc
major
surfac
membran
glycoprotein
requir
viru
attach
fusion
previous
report
mab
effect
neutral
hev
nivm
well
nivb
strain
surprisingli
mab
effici
neutral
nivm
strain
nivb
strain
complet
neutral
amino
acid
chang
g
nivm
nivb
howev
mutat
residu
associ
escap
neutral
mab
one
interestingli
mutat
residu
present
nivb
could
affect
structur
loop
respons
interact
ephrin
molecul
previous
shown
mab
recogn
conform
epitop
nivm
g
bind
affect
nglycosyl
site
stalk
region
neutralizationescap
mutat
identifi
studi
detect
hnv
g
mutat
present
f
surpris
sinc
mab
use
studi
target
hnv
g
two
neutralizationescap
mutant
amino
acid
chang
nivm
share
mutat
residu
mutat
unlik
play
role
neutral
escap
sinc
escap
mutant
refractori
neutral
respect
mab
suggest
uniqu
chang
common
residu
play
role
neutral
escap
mab
function
chang
associ
neutral
escap
remain
unknown
possibl
compensatori
chang
posit
critic
cystein
niv
g
stalk
region
mediat
coval
subunit
dimer
residu
also
predict
glycosyl
site
play
crucial
role
membran
fusion
f
trigger
four
residu
associ
escap
neutral
near
within
receptorbind
domain
locat
hnv
g
mutat
nivm
hev
respect
previous
shown
disrupt
bind
maintain
high
affin
ephrin
crystal
structur
deriv
bound
hev
g
show
resembl
gh
loop
ephrin
shape
insert
angl
hev
g
bind
pocket
hev
escap
mutant
adjac
anoth
bind
pocket
hev
g
respons
interact
ephrin
residu
final
mutat
affect
hydrogen
bond
nivm
g
ephrin
respect
impart
affin
stabil
receptorbound
complex
hydrogen
bond
involv
area
contain
salt
bridg
hydrogen
bond
mutat
close
found
nivb
strain
could
explain
nivb
strain
effici
neutral
mab
interestingli
epitop
also
miss
recent
describ
hnv
isol
ghanaian
bat
suggest
viru
would
suscept
neutral
mab
note
neutralizationescap
mutant
current
studi
gener
artifici
condit
sinc
viral
protein
undergo
conform
chang
differ
physiolog
condit
abil
kinet
figur
effect
neutral
escap
replic
henipavirus
hamster
lung
black
bar
brain
white
bar
titer
result
hamster
infect
wildtyp
wt
neutralizationescap
mutant
hendra
viru
hev
nipah
viru
strain
malaysia
nivm
b
moribund
lung
brain
tissu
harvest
infect
hamster
moribund
assay
infecti
viru
describ
materi
method
section
tissu
sampl
anim
analyz
error
bar
repres
standard
deviat
p
analysi
varianc
compar
wt
strain
mab
bind
g
depend
environ
could
potenti
affect
escap
variant
aris
therefor
would
interest
compar
neutralizationescap
mutant
gener
vitro
gener
vivo
previous
shown
escap
neutral
associ
reduc
viral
fit
sever
neutralizationescap
mutat
receptorbind
domain
sar
coronaviru
result
reduc
replic
varieti
cell
reduc
virul
mice
current
studi
sever
amino
acid
associ
neutral
escap
previous
shown
directli
involv
bind
receptor
ephrin
recent
studi
shown
mutat
nivm
hev
g
respect
result
signific
differ
replic
vitro
expand
find
test
vitro
replic
neutralizationescap
mutant
although
least
mutat
locat
within
receptorbind
domain
chang
propag
detect
chang
result
lower
titer
hour
infect
suggest
entri
may
affect
mutat
viru
replic
affect
cell
cultur
signific
attenu
observ
mutant
hamster
model
sever
neutralizationescap
mutat
nivm
g
result
signific
delay
time
death
day
addit
reduct
viru
titer
observ
lung
brain
tissu
consid
key
target
organ
hnv
infect
hamster
develop
neutralizationescap
mutant
affect
vitro
vivo
replic
potenti
concern
develop
neutral
mab
treatment
prophylaxi
howev
treatment
nonhuman
primat
day
infect
complet
protect
lethal
infect
nivm
hev
evid
found
emerg
neutralizationescap
mutant
model
conclus
character
sever
mab
recogn
distinct
epitop
hnv
g
sever
mab
target
epitop
directli
involv
receptor
bind
thu
like
inhibit
crucial
first
step
viru
infect
cocktail
mab
may
preferenti
singl
mab
given
fact
escap
neutral
occur
without
affect
virul
supplementari
materi
avail
http
jidoxfordjournalsorg
consist
data
provid
author
benefit
reader
post
materi
copyedit
sole
respons
author
question
comment
address
author
